Incomplete dissociation of glibenclamide from wild-type and mutant pancreatic K_ATP channels limits their recovery from inhibitionRUSS, U; PRAGER, R et al.British journal of pharmacology. 2009, Vol 156, Num 2, pp 354-361, issn 0007-1188, 8 p.Article

3 Sulfamides et cœur: Le point sur les données des principales études : Complications métaboliques induites par différents traitementsVERGES, Bruno.Diabète & obésité. 2014, Vol 9, Num 81, pp 203-205, issn 1957-5238, 3 p.Article

Antidiabetic activity of aqueous bark extract of Cassia glauca in streptozotocin-induced diabetic ratsSALAHUDDIN, Md; JALALPURE, Sunil S; GADGE, Navneet B et al.Canadian journal of physiology and pharmacology. 2010, Vol 88, Num 2, pp 153-160, issn 0008-4212, 8 p.Article

Optimization of glibenclamide tablet composition through the combined use of differential scanning calorimetry and D-optimal mixture experimental designMURA, P; FURLANETTO, S; CIRRI, M et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 37, Num 1, pp 65-71, issn 0731-7085, 7 p.Article

The effect of gliclazide and glibenclamide on preconditioning of the human myocardiumLOUBANI, Mahmoud; FOWLER, Alan; STANDEN, Nicholas B et al.European journal of pharmacology. 2005, Vol 515, Num 1-3, pp 142-149, issn 0014-2999, 8 p.Article

Sulfonylurées et effets cardiovasculaires : de l'expérimentation à la clinique. Données disponibles chez l'homme et implications cliniques = Sulfonylureas and cardiovascular effects : From the laboratory to the bedside, clinical data and implications in manRIVELINE, Jean-Pierre; VARROUD-VIAL, Michel; CHARPENTIER, Guillaume et al.STV. Sang thrombose vaisseaux. 2006, Vol 18, Num 7, pp 367-377, issn 0999-7385, 11 p.Article

GLIBENCLAMIDE REDUCES SECONDARY BRAIN DAMAGE AFTER EXPERIMENTAL TRAUMATIC BRAIN INJURYZWECKBERGER, K; HACKENBERG, K; JUNG, C. S et al.Neuroscience. 2014, Vol 272, pp 199-206, issn 0306-4522, 8 p.Article

Hair to document exposure to glibenclamideVILLAIN, Marion; TOUMOUD, Christine; FLESCH, Francoise et al.Journal of chromatography. B. 2006, Vol 842, Num 2, pp 111-115, issn 1570-0232, 5 p.Conference Paper

The mutation Y1206S increases the affinity of the sulphonylurea receptor SUR2A for glibenclamide and enhances the effects of coexpression with Kir6.2STEPHAN, Damian; STAUSS, Eva; LANGE, Ulf et al.British journal of pharmacology. 2005, Vol 144, Num 8, pp 1078-1088, issn 0007-1188, 11 p.Article

Development and evaluation of glyburide fast dissolving tablets using solid dispersion techniqueVALLERI, M; MURA, P; MAESTRELLI, F et al.Drug development and industrial pharmacy. 2004, Vol 30, Num 5, pp 525-534, issn 0363-9045, 10 p.Article

Differential effects of glucose and glyburide on energetics and Na⁺ levels of βHC9 cells: Nuclear magnetic resonance spectroscopy and respirometry studiesDOLIBA, Nicolai M; VATAMANIUK, Marko Z; BUETTGER, Carol W et al.Diabetes (New York, NY). 2003, Vol 52, Num 2, pp 394-402, issn 0012-1797, 9 p.Article

Are We Optimizing Gestational Diabetes Treatment With Glyburide? The Pharmacologic Basis for Better Clinical PracticeHEBERT, M. F; MA, X; KELLY, E. J et al.Clinical pharmacology and therapeutics. 2009, Vol 85, Num 6, pp 607-614, issn 0009-9236, 8 p.Article

When replication teaches more than the original experiment — the saga of the unknown unknown : NIH REPLICATION STUDIESMARC SIMARD, J; GERZANICH, Volodymyr.Experimental neurology (Print). 2012, Vol 233, Num 2, pp 623-624, issn 0014-4886, 2 p.Article

Traitement du diabète gestationnel par hypoglycémiants oraux = Treatment of gestational diabetes with oral hypoglycemic agentsCARLES, G; GERMAIN, L; ALASSAS, N et al.Journal de gynécologie obstétrique et biologie de la reproduction. 2010, Vol 39, Num 2, pp 139-143, issn 0368-2315, 5 p.Article

Le médicament du mois. Glucovance® dans le diabète de type 2, une association fixe metformine-glibenclamide pour faciliter le traitement d'une maladie bipolaire = Glucovance® in type 2 diabetes, a fixed metformin-glibenclamide combined therapy for a bipolar metabolic diseaseSCHEEN, A. J.RMLG. Revue médicale de Liège. 2003, Vol 58, Num 6, pp 448-452, issn 0370-629X, 5 p.Article

Resveratrol supplementation improves glycemic control in type 2 diabetes mellitusKUMAR BHATT, Jayesh; THOMAS, Sabin; JOGHEE NANJAN, Moola et al.Nutrition research (New York, NY). 2012, Vol 32, Num 7, pp 537-541, issn 0271-5317, 5 p.Article

Genetic risk factors for type 2 diabetes mellitus and response to sulfonylurea treatmentSWEN, Jesse J; GUCHELAAR, Henk-Jan; BAAK-PABLO, Renee F et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 8, pp 461-468, issn 1744-6872, 8 p.Article

The effect of glibenclamide on acetylcholine and sodium nitroprusside induced vasodilatation in human cutaneous microcirculationHOJS, Nina; STRUCL, Martin; CANKAR, Ksenija et al.Clinical physiology and functional imaging (Print). 2009, Vol 29, Num 1, pp 38-44, issn 1475-0961, 7 p.Article

Inhibition of 1-methyl-4-phenylpyridinium-induced mitochondrial dysfunction and cell death in PC12 cells by sulfonylurea glibenclamideCHUNG SOO LEE; YUN JEONG KIM; HYUN HEE KO et al.European journal of pharmacology. 2005, Vol 527, Num 1-3, pp 23-30, issn 0014-2999, 8 p.Article

The sulfonylurea glipizide does not inhibit ischemic preconditioning in anesthetized rabbitsFLYNN, David M; SMITH, Andrew H; KNIGHT, Delvin R et al.Cardiovascular drugs and therapy. 2005, Vol 19, Num 5, pp 337-346, issn 0920-3206, 10 p.Article

Localization and function of ATP-sensitive potassium channels in human skeletal muscleNIELSEN, Jens Jung; KRISTENSEN, Michael; HELLSTEN, Ylva et al.American journal of physiology. Regulatory, integrative and comparative physiology. 2003, Vol 53, Num 2, pp R558-R563, issn 0363-6119Article

Glibenclamide induced photosensitivitySINGAL, Archana; BHATTACHARYA, S. N; BARUAH, M. C et al.Indian Journal of Dermatology Venereology and Leprology. 2002, Vol 68, Num 4, pp 240-241, issn 0378-6323, 2 p.Article

SRMS142-based solid lipid microparticles: Application in oral delivery of glibenclamide to diabetic ratsNNAMANI, P. O; ATTAMA, A. A; IBEZIM, E. C et al.European journal of pharmaceutics and biopharmaceutics. 2010, Vol 76, Num 1, pp 68-74, issn 0939-6411, 7 p.Article

Glibenclamide modulates glucantime activity and disposition in Leishmania majorPADRON-NIEVES, Maritza; DIAZ, Emilia; MACHUCA, Claudia et al.Experimental parasitology. 2009, Vol 121, Num 4, pp 331-337, issn 0014-4894, 7 p.Article

Lipids modulate ligand binding to sulphonylurea receptorsKLEIN, Alexander; LICHTENBERG, Jochen; STEPHAN, Damian et al.British journal of pharmacology. 2005, Vol 145, Num 7, pp 907-915, issn 0007-1188, 9 p.Article